rhein has been researched along with Astrocytoma, Grade IV in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Caron, G; Ermondi, G; Gabano, E; Gariboldi, MB; Marras, E; Ravera, M; Vallaro, M | 1 |
| Chen, J; Luo, B; Pi, R; Wen, S | 1 |
| Benassi, M; Bruno, T; Fanciulli, M; Floridi, A; Gentile, FP; Paggi, MG | 1 |
3 other study(ies) available for rhein and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Application of the anthraquinone drug rhein as an axial ligand in bifunctional Pt(IV) complexes to obtain antiproliferative agents against human glioblastoma cells.
Topics: Anthraquinones; Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Glioblastoma; Humans; Ligands; Prodrugs | 2022 |
Discovery of a novel rhein-SAHA hybrid as a multi-targeted anti-glioblastoma drug.
Topics: Anthraquinones; Antineoplastic Agents; Biological Availability; Cell Line, Tumor; Cell Movement; Cell Proliferation; Glioblastoma; Glioma; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Immediate-Early Proteins; Neoplasm Invasiveness; Protein Serine-Threonine Kinases; Vorinostat | 2020 |
Inhibition of membrane redox activity by rhein and adriamycin in human glioma cells.
Topics: Anthraquinones; Cell Membrane; Cell Survival; Doxorubicin; Electron Transport; Ferricyanides; Glioblastoma; Humans; NADH, NADPH Oxidoreductases; Oxidation-Reduction; Tumor Cells, Cultured | 1992 |